Zubin Bhagwagar, MBBS, MD, FRCPsych, DPhil

Zubin is a physician scientist with 30 years of experience in academia and the pharmaceutical industry. His area of expertise includes clinical development and business development in neuroscience and rare diseases. He is the Vice President of External Innovation at Intra Cellular Therapies, a Johnson and Johnson company. Previous positions include Chief Medical Officer at Certego Therapeutics, SVP R&D at Rallybio (a rare disease focussed biotech which went public in 2021), and Vice President and Head of External Innovation at Alexion Pharmaceuticals, where he also led the Strategic Evaluation team in Business Development. He previously held positions of increasing responsibility at Bristol-Myers Squibb, where he worked in multiple therapeutic areas including neuroscience and clinical pharmacology and was in academia prior to BMS.

Zubin received his medical degree and completed his psychiatry residency at Delhi University. He subsequently completed another residency in psychiatry at the University of Oxford, where he was awarded a DPhil (Ph.D.) in neuroimaging and neurobiology. He is a Fellow of the Royal College of Psychiatrists (UK), the American College of Neuropsychopharmacology, and the American Psychiatric Association and has authored more than 85 papers in neuroscience/psychiatry. He has been on the faculty of the Department of Psychiatry at Yale University School of Medicine since 2005, where he is an Adjunct Associate Professor.